These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 27087250)

  • 21. Association of angiotensin-converting enzyme inhibitor therapy initiation with a reduction in hemoglobin levels in patients without renal failure.
    Leshem-Rubinow E; Steinvil A; Zeltser D; Berliner S; Rogowski O; Raz R; Chodick G; Shalev V
    Mayo Clin Proc; 2012 Dec; 87(12):1189-95. PubMed ID: 23141116
    [TBL] [Abstract][Full Text] [Related]  

  • 22. End-stage renal disease and adherence to angiotensin-converting enzyme inhibitors and angiotensin receptor blockers among patients with diabetes.
    Shani M; Vinker S; Feldman L
    J Clin Hypertens (Greenwich); 2017 Jun; 19(6):627-631. PubMed ID: 28177196
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association of Changes in Medication Use and Adherence With Accountable Care Organization Exposure in Patients With Cardiovascular Disease or Diabetes.
    McWilliams JM; Najafzadeh M; Shrank WH; Polinski JM
    JAMA Cardiol; 2017 Sep; 2(9):1019-1023. PubMed ID: 28700790
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Relationship of the magnitude of member cost-share and medication persistence with newly initiated renin angiotensin system blockers.
    Zhang D; Carlson AM; Gleason PP; Schondelmeyer SW; Schommer JC; Dowd BE; Heaton AH
    J Manag Care Pharm; 2007 Oct; 13(8):664-76. PubMed ID: 17970604
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association Between Angiotensin-Converting Enzyme Inhibitors, Angiotensin Receptor Blockers, and Suicide.
    Mamdani M; Gomes T; Greaves S; Manji S; Juurlink DN; Tadrous M; Kennedy SH; Antoniou T
    JAMA Netw Open; 2019 Oct; 2(10):e1913304. PubMed ID: 31617924
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Telepharmacy and medication adherence in urban areas.
    Guadamuz JS; McCormick CD; Choi S; Urick B; Alexander GC; Qato DM
    J Am Pharm Assoc (2003); 2021; 61(2):e100-e113. PubMed ID: 33246835
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of the first year of a pilot program in community pharmacy: HIV/AIDS medication therapy management for Medi-Cal beneficiaries.
    Hirsch JD; Rosenquist A; Best BM; Miller TA; Gilmer TP
    J Manag Care Pharm; 2009; 15(1):32-41. PubMed ID: 19125548
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Determinants of adherence to diabetes medications: findings from a large pharmacy claims database.
    Kirkman MS; Rowan-Martin MT; Levin R; Fonseca VA; Schmittdiel JA; Herman WH; Aubert RE
    Diabetes Care; 2015 Apr; 38(4):604-9. PubMed ID: 25573883
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Physician-specific variation in medication adherence among diabetes patients.
    Sherman BW; Sekili A; Prakash ST; Rausch CA
    Am J Manag Care; 2011 Nov; 17(11):729-36. PubMed ID: 22084892
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Incidence of and Risk Factors for Severe Adverse Events in Elderly Patients Taking Angiotensin-Converting Enzyme Inhibitors or Angiotensin II Receptor Blockers after an Acute Myocardial Infarction.
    Fang G; Annis IE; Farley JF; Mahendraratnam N; Hickson RP; Stürmer T; Robinson JG
    Pharmacotherapy; 2018 Jan; 38(1):29-41. PubMed ID: 29059475
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Trends in medication adherence in HIV patients in the US, 2001 to 2012: an observational cohort study.
    Youn B; Shireman TI; Lee Y; Galárraga O; Wilson IB
    J Int AIDS Soc; 2019 Aug; 22(8):e25382. PubMed ID: 31441221
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Angiotensin-Converting Enzyme Inhibitors or Angiotensin Receptor Blockers Use and COVID-19 Infection Among 824 650 Patients With Hypertension From a US Integrated Healthcare System.
    An J; Wei R; Zhou H; Luong TQ; Gould MK; Mefford MT; Harrison TN; Creekmur B; Lee MS; Sim JJ; Brettler JW; Martin JP; Ong-Su AL; Reynolds K
    J Am Heart Assoc; 2021 Feb; 10(3):e019669. PubMed ID: 33307964
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prescriber continuity and medication adherence for complex patients.
    Hansen RA; Voils CI; Farley JF; Powers BJ; Sanders LL; Sleath B; Maciejewski ML
    Ann Pharmacother; 2015 Mar; 49(3):293-302. PubMed ID: 25549627
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Changes in adherence to evidence-based medications in the first year after initial hospitalization for heart failure: observational cohort study from 1994 to 2003.
    Lamb DA; Eurich DT; McAlister FA; Tsuyuki RT; Semchuk WM; Wilson TW; Blackburn DF
    Circ Cardiovasc Qual Outcomes; 2009 May; 2(3):228-35. PubMed ID: 20031842
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Combining zip code-based population data and pharmacy administrative claims data to create measures of social determinants of health.
    Hunter BD; Brown-Gentry KD; Santilli MA; Prasla K
    J Manag Care Spec Pharm; 2024 Apr; 30(4):364-375. PubMed ID: 38555626
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of the diabetes Canada guideline dissemination strategy on dispensed vascular protective medications for older patients in Ontario, Canada: a linked EMR and administrative data study.
    Greiver M; Kalia S; Moineddin R; Chen S; Duchen R; Rigobon A
    BMC Health Serv Res; 2020 May; 20(1):370. PubMed ID: 32357891
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The implications of therapeutic complexity on adherence to cardiovascular medications.
    Choudhry NK; Fischer MA; Avorn J; Liberman JN; Schneeweiss S; Pakes J; Brennan TA; Shrank WH
    Arch Intern Med; 2011 May; 171(9):814-22. PubMed ID: 21555659
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of Angiotensin Converting Enzyme Inhibitor versus Angiotensin Receptor Blocker on Incidence of New-Onset Diabetes Mellitus in Asians.
    Park JY; Rha SW; Choi BG; Choi SY; Choi JW; Ryu SK; Lee SJ; Kim S; Noh YK; Akkala RG; Li H; Ali J; Kim JB; Lee S; Na JO; Choi CU; Lim HE; Kim JW; Kim EJ; Park CG; Seo HS; Oh DJ
    Yonsei Med J; 2016 Jan; 57(1):180-6. PubMed ID: 26632399
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers on all-cause mortality, cardiovascular deaths, and cardiovascular events in patients with diabetes mellitus: a meta-analysis.
    Cheng J; Zhang W; Zhang X; Han F; Li X; He X; Li Q; Chen J
    JAMA Intern Med; 2014 May; 174(5):773-85. PubMed ID: 24687000
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Medication Nonadherence Among Medicare Beneficiaries with Comorbid Chronic Conditions: Influence of Pharmacy Dispensing Channel.
    Iyengar RN; LeFrancois AL; Henderson RR; Rabbitt RM
    J Manag Care Spec Pharm; 2016 May; 22(5):550-60. PubMed ID: 27123916
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.